Key result
Male gender was an independent predictor of 5-year mortality (HR 2.7; 95% CI 1.1-6.5; P=0.02), and male Takotsubo syndrome patients had significantly higher mortality than male ACS patients.
Why the study?
Recent studies have highlighted a mortality rate in Takotsubo syndrome similar to ACS, but the impact of gender differences on outcomes compared with ACS patients remained to be evaluated.
Does male gender impact the short-term clinical events and long-term prognosis in patients with Takotsubo Syndrome compared to Acute Coronary Syndrome?
Cohort (n=438)
No
Does male gender impact the short-term clinical events and long-term prognosis in patients with Takotsubo Syndrome compared to Acute Coronary Syndrome?
Male patients with Takotsubo syndrome experience more severe acute complications and have a poorer long-term prognosis compared to male patients with acute coronary syndrome.
Answers are grounded in this paper and cite their sources.
Male Takotsubo patients face excess long-term mortality versus ACS; leaves open whether gender-tailored surveillance improves outcomes.
BACKGROUND: Takotsubo Syndrome (TTS) is an acute reversible left ventricular dysfunction. Recently published studies have highlighted a similar mortality rate as acute coronary syndrome (ACS). We compared the impact of gender differences on the outcome of TTS patients as compared to ACS patient. DESIGN AND METHODS: We included a collective of 138 patients TTS between 2003 and 2016 at our institution. Patients were divided according to their gender into two groups (Males n=21, 15% and females, n=117, 85%). They were compared with a cohort of 300 patients with a diagnosis of ACS. RESULTS: On the acute phase, in male patients with TTS, a treatment with inotropic was more often required (33.3 vs. 11.5%, P<0.01), were more susceptible to cardiogenic shock (28.6 vs. 12.5%, P<0.04). Concerning the long-term prognosis after the acute event, male patients had higher all-cause mortality over long-term follow-up. A Kaplan-Meier analysis indicated that the mortality of male patients with TTS was significantly higher compared to male patients with ACS (log-rank <0.01), while there was no significant difference between female patients with TTS and ACS (log-rank =0.60, P=0.45). In a multivariate cox regression analysis, male gender (HR 2.7, 95% CI: 1.1-6.5, P=0.02) GFR <60 ml/min (HR 2.8, 95% CI: 1.2-6.0, P=0.01) and history of cancer (HR 3.6, 95% CI 1.4-9.3, P<0.01) were independent predictors of 5-year mortality. CONCLUSIONS: Considerable evidence suggests that TTS compared to ACS implicates more significant clinical short-term events on male patients and it may be associated with poorer long-term prognosis.
No takes yet. Share an insight, caveat, or question.
Giannakopoulos et al. (2019) conducted a cohort in Takotsubo Syndrome and Acute Coronary Syndrome (n=438). Male gender vs. Female gender was evaluated on 5-year mortality (HR 2.7, 95% CI 1.1-6.5, p=0.02). Male gender was an independent predictor of 5-year mortality (HR 2.7; 95% CI 1.1-6.5; P=0.02), and male Takotsubo syndrome patients had significantly higher mortality than male ACS patients.
Synapse has enriched 10 related papers. Consider them for comparative context: